Abstract
The objective of this report was to evaluate the ascitic fluid of a patient with refractory lupus ascites (proband) at different time points—pre- and post-intraperitoneal treatment with dexamethasone—using a multiparametric approach which included the presence of autoantibodies and pro- and anti-inflammatory cytokines and chemokines, and a proteomic analysis. As controls, we studied two additional patients also with lupus ascites (only at basal evaluation) and two patients with ascites due to alcoholic liver cirrhosis. High levels of anti-dsDNA and anti-nucleosomes autoantibodies were detected in the ascitic fluid of all lupus patients and remained elevated in the proband throughout the follow-up. All lupus patients have detectable ascitic high levels of IL-6, IL-8, IL-10, TNF-α, MCP-1, and IGF-1 which diminished gradually in the proband after intraperitoneal dexamethasone. In the proteomic analysis of the ascitic fluid, a marked increment of apolipoprotein A1 was observed and again, it diminished gradually after intraperitoneal treatment. Our findings further support the use of intraperitoneal steroids as an effective therapeutic option for refractory ascites in systemic lupus erythematosus.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Man B, Mok C (2005) Serositis to systemic lupus erythematosus: prevalence and outcome. Lupus 14:822–826
Pott H, Neto A, Barone M et al (2012) Ascitis due to lupus peritonitis: a rare form of onset of systemic lupus erythematosus. Rev Bras Reumatol 52:113–119
Aljebreen A, Al-Mogairen S (2014) Refractroy ascites as the first presentation of systemic lupus erythematosus. Arab J Gastroenterol 15:161–162
Rongquan L, Zhang K, Gao S et al (2014) Gastrointestinal symptom due to lupus peritonitis: a rare form of onset of SLE. Int J Clin Exp Med 7:5917–5920
Ito H, Nahamiya W, Kuroda N et al (2002) Chronic lupus peritonitis with massive ascites at elderly onset: case report and review of the literature. Intern Med 41:1056–1061
Zhou Q, Yang X, Hou F et al (2009) Successful treatment of massive ascites with intraperitoneal administration of a steroid in a case of systemic lupus erythematosus. Lupus 8:740–742
Forouhar-Graff H, KA D-Y, Parke A (2011) Insidious onset of massive painless ascites as initial manifestation of systemic lupus erythematosus. Lupus 20:754–757
Wang H, Lin JX, Li P et al (2015) New insights into heterogeneity of peritoneal B-1a cells. Ann N Y Acad Sci 1362:68–76
Watanabe R, Fujii H, Kamogawa Y et al (2015) Chronic lupus peritonitis is characterized by the ascites with a large content of interleukin-6. Tohoku J Exp Med 235:289–294
Lee MJ, Shin DH, Ko KI et al (2013) Association between the ratio of insulin-like growth factor-I to insulin-like growth factor binding protein-3 and inflammation in incident automated peritoneal dialysis patients. Growth Hormon IGF Res 23:170–174
Peng H, Wang W, Zhou M et al (2013) Role of interleukin-10 and interleukin-10 receptor in systemic lupus erythematosus. Clin Rheumatol 32:1255–1266
Antonelli A, Ferrari SM, Giuggioli D et al (2014) Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. Autoimmun Rev 13:272–280
Gupta R, Misra SP, Dwivedi M et al (2001) Diagnosing ascites: value of ascitic fluid total protein, albumin, cholesterol, their ratios, serum-ascites albumin and cholesterol gradient. J Gastroenterol Hepatol 10:295–299
Jüngst D, Xie Y, Gerbes AL (1992) Pathophysiology of elevated ascites fluid cholesterol in malignant ascites. Increased ascites to serum relation of proteins and lipoproteins in patients with peritoneal carcinomatosis as compared to patients with cirrhosis of the liver. J Hepatol 14:244–248
Wiig H, Swartz MA (2012) Interstitial fluid and lymph formation and transport: physiological regulation and roles in inflammation and cancer. Physiol Rev 92:1005–1060
Hyka N, Dayer JM, Modoux C et al (2001) Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes. Blood 97:2381–2389
Wilhelm AJ, Zabalawi M, Owen JS et al (2010) Apolipoprotein A-I modulates regulatory T cells in autoimmune LDLr−/−, ApoA-I−/− mice. J Biol Chem 285:36158–36169
Provenzano G, Rinaldi F, Le Moli S et al (1993) Chronic lupus peritonitis responsive to treatment with cyclophosphamide. Br J Rheumatol 32:1116
Shcousboe J, Koch A, Chang R (1998) Chronic lupus peritonitis with ascitis: review of the literature with a case report. Semin Arthritis Rheu 18:121–126
Kaklamanis P, Vayopolos G, Stametelos G (1991) Chronic lupus peritonitis with ascities. Ann Rheum Dis 50:176–177
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Written informed consent was collected from participants. The study was approved by the Institutional Research Board of the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. The study was carried out according to the principles of the Helsinki Declaration.
Funding
The study did not have any funding.
Disclosures
None.
Rights and permissions
About this article
Cite this article
Atisha-Fregoso, Y., Hernández-Ramírez, D.F., Olivares-Martínez, E. et al. Refractory ascites in systemic lupus erythematosus: further biological support of intraperitoneal steroid treatment as a suitable therapeutical option. Clin Rheumatol 36, 707–711 (2017). https://doi.org/10.1007/s10067-016-3473-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-016-3473-9